|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.76 USD | -4.50% |
|
+1.47% | +18.45% |
| May. 09 | Earnings Flash (VYNE) VYNE THERAPEUTICS Posts Q1 Revenue $98,000 | MT |
| May. 09 | VYNE Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
VYNE Therapeutics Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported revenue was USD 0.477 million compared to USD 0.931 million a year ago. Net loss was USD 23.21 million compared to USD 73.33 million a year ago.
Basic loss per share from continuing operations was USD 10.65 compared to USD 15.46 a year ago. Basic loss per share was USD 7.28 compared to USD 25.64 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +18.45% | 40.75M | |
| +31.37% | 588B | |
| -2.60% | 364B | |
| +20.83% | 326B | |
| +5.69% | 285B | |
| +14.83% | 239B | |
| +9.93% | 210B | |
| -6.95% | 200B | |
| +10.77% | 167B | |
| +0.10% | 161B |
VYNE THERAPEUTICS INC. 